Community-Acquired Pneumonia: The Importance of the Early Detection of Drug-Resistant Organisms

Authors

Sai Doppalapudi
Muhammad Adrish

Publication Date

6-9-2024

Journal

World Journal of Critical Care Medicine

DOI

10.5492/wjccm.v13.i2.91314

PMID

38855277

PMCID

PMC11155498

PubMedCentral® Posted Date

6-9-2024

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Keywords

Methicillin-resistant Staphylococcus aureus, Polymerase chain reaction, Antibiotic resistance, Bacterial colonization, Infective endocarditis

Abstract

Pneumonia is a disease associated with significant healthcare burden with over 1.5 million hospitalizations annually and is the eighth leading cause of death in the United States. While community-acquired pneumonia (CAP) is generally considered an acute time-limited illness, it is associated with high long-term mortality, with nearly one-third of patients requiring hospitalization dying within one year. An increasing trend of detecting multidrug-resistant (MDR) organisms causing CAP has been observed, especially in the Western world. In this editorial, we discuss about a publication by Jatteppanavar